Swiss SMI rises 0.66% as all 20 stocks finish higher

Switzerland’s main stock index, the SMI, rose 0.66% on Monday to close at 13,877.84 points.

All 20 companies in the index finished higher, with Galderma and Sandoz each up 1.9%.

Galderma’s shares continued to benefit from encouraging three-year data for its eczema drug Nemluvio.

Novartis and Roche also gained, helping lift the market.

Outside the SMI, Adecco fell 8.2% after a competitor released results, while AMS Osram dropped 5.9%.

Investors were also buying shares in Givaudan and Lonza ahead of their quarterly results due Tuesday and Wednesday.

Those results are among the updates investors will watch as the earnings season gets under way.